Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064740 · ClinicalTrials.gov registry record · Phase 2
Relaxation Response With Acupuncture for HIV Patients
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00064740 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 100 participants.
The verdict
NCT00064740, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
Advances in treatment has turned HIV/AIDS into a chronic illness. Relaxation response is a state in which individuals evoke a bodily calm, effecting physiological changes that are shown to be associated with improved immune functioning. Acupuncture and relaxation are thought to both induce calm and deep relaxation in mind and body. This trial will study the combined effects of acupuncture and relaxation response in HIV patients.
Interventions
- BEHAVIORAL relaxation response
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-07 |
| Est. Completion | 2006-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00064740
The ClinicalTrials.gov registry entry for NCT00064740 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which relaxation response is the first listed.
NCT00064740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00064740 about?
NCT00064740 is a clinical study titled "Relaxation Response With Acupuncture for HIV Patients". Advances in treatment has turned HIV/AIDS into a chronic illness. Relaxation response is a state in which individuals evoke a bodily calm, effecting physiological changes that are shown to be associated with improved immune functioning. Acupuncture and relaxation are thought to both induce calm and ...
What is the current status of trial NCT00064740?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2003-07. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00064740?
The interventions under investigation include: relaxation response (BEHAVIORAL).
Who is sponsoring clinical trial NCT00064740?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.